NSE
Shilpa Medicare LimitedSHILPAMED
Shilpa Medicare Limited is an NSE-listed company (SHILPAMED).
AI-generated overview — verify before relying on it.
Net institutional flow
+₹37.4 Cr
Institutional buyers
1 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Bonus 1:1
ex 2025-10-03
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹7.2 Cr | 154 | — | — | — | — |
| 2 | MOBIKWIK | +₹0.1 Cr | 83 | — | — | — | — |
| 3 | QUADFUTURE | +₹0 Cr | 134 | — | — | — | — |
| 4 | SHILPAMEDThis | — | — | — | — | — | — |
| 5 | MTNL | +₹0 Cr | 2 | — | — | — | — |
| 6 | GATECH | +₹0 Cr | 8 | — | — | — | — |
| 7 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2025-10-03ActionBonus 1:1Bonus
- 2025-09-17ActionDividend - Re 1 Per ShareDividend
- 2025-03-21BulkBUY · ₹37.4 CrTHE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
- 2025-03-21NetDay net +₹37.4 Cr
- 2025-01-23BlockBUY · ₹13.3 CrUBS AG
- 2025-01-23BlockSELL · ₹13.3 CrUBS PRINCIPAL CAPITAL ASIA LIMITED
- 2024-09-06ActionAnnual General MeetingMeeting
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
No scored filings for SHILPAMED yet.
3 deals · 2025-01-23 → 2025-03-21
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-03-21 | THE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | Institution | BUY | ₹37.4 Cr |
| 2025-01-23 | UBS AG | HNI / other | BUY | ₹13.3 Cr |
| 2025-01-23 | UBS PRINCIPAL CAPITAL ASIA LIMITED | HNI / other | SELL | ₹13.3 Cr |
3 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on SHILPAMED
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.